Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein
β Scribed by Marc Ruel; Roger J. Laham; J.Anthony Parker; Mark J. Post; J.Anthony Ware; Michael Simons; Frank W. Sellke
- Book ID
- 114490510
- Publisher
- CTSNet
- Year
- 2002
- Tongue
- English
- Weight
- 69 KB
- Volume
- 124
- Category
- Article
- ISSN
- 1097-685X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Effects of human recombinant acidic fibroblast growth factor (haFGF) on longβterm potentiation (LTP) and the increase of the spike amplitude induced by weak tetanic stimulation were investigated and compared with those of CS23 (modified human basic FGF) in the dentate gyrus of fasted an
The effects of fetal bovine serum, insulin-like growth factor-I, and fibroblast growth factor-2 on the regulation of the functional physical properties of adult bovine cartilage explants during an incubation period of 18-20 days was determined, and the relationship between the measured functional pr
Fibroblast growth factors (FGF) are a family of heparin-binding angiogenic polypeptide mitogens. In the presence of heparin, recombinant human basic fibroblast growth factor (bFGF) is fully protected from tryptic digestion and partially protected from chymotryptic digestion. Complete protection of b
## Abstract The aim of this study was to accelerate angiogenesis in necrotic bone by combining vascular bundle implantation and fibroblast growth factorβ2 (FGFβ2) administration. Twentyβfour Japanese white rabbits were evaluated in this study. A portion of a rabbit iliac crest bone was removed as